1. CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway
   Usama Khamis Hussein et al, 2021, Cells CrossRef
2. Protein kinase CK2 modulation of pyruvate kinase M isoforms augments the Warburg effect in cancer cells
   Kyung Mi Yang et al, 2018, Journal of Cellular Biochemistry CrossRef
3. CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(−) HNSCC Cell Lines
   Janeen H. Trembley et al, 2021, Biomedicines CrossRef
4. Targeting CK2 in cancer: a valuable strategy or a waste of time?
   Mauro Salvi et al, 2021, Cell Death Discovery CrossRef
5. Co-expression network analysis identifies a gene signature as a predictive biomarker for energy metabolism in osteosarcoma
   Naiqiang Zhu et al, 2020, Cancer Cell International CrossRef
6. Protein kinase CK2: a potential therapeutic target for diverse human diseases
   Christian Borgo et al, 2021, Signal Transduction and Targeted Therapy CrossRef
7. Cancer-type dependent expression of CK2 transcripts
   Melissa M. J. Chua et al, 2017, PLOS ONE CrossRef
8. Scoping Pleiotropy of CK2 in Musculoskeletal Disorders for a Novel Targeting Approach
   Venu Pandit et al, 2024, Kinases and Phosphatases CrossRef
9. Molecular targets and therapeutic strategies for triple-negative breast cancer
   Yashasvi Bhat et al, 2023, Molecular Biology Reports CrossRef
10. 4,5,7‐Trisubstituted indeno[1,2‐b]indole inhibits CK2 activity in tumor cells equivalent to CX‐4945 and shows strong anti‐migratory effects
    Robin Birus et al, 2022, FEBS Open Bio CrossRef
11. Synthesis and biological evaluation of novel amino-substituted derivatives of pyrido[2,3-d]pyrimidine as inhibitors of protein kinase CK2
    A. N. Zinchenko et al, 2017, Biopolymers and Cell CrossRef
12. CK2 Inhibitors Targeting Inside and Outside the Catalytic Box
    Sophie Day-Riley et al, 2024, Kinases and Phosphatases CrossRef
13. Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease
    Katsutoshi Sato et al, 2021, Nature Communications CrossRef